FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:581-584 August 24, 2000 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Robertson, D. Related Article by Antman, K.

To the Editor: In their review of Kaposi's sarcoma, Drs. Antman and Chang (April 6 issue)¹ thoroughly discuss the therapeutic options for advanced and aggressive Kaposi's sarcoma and conclude that "all the drugs studied so far have clinically significant systemic side effects." Treatment options for cases of less severe disease were omitted from the discussion by Antman and Chang.

Until recently, the treatment of less severe cutaneous Kaposi's sarcoma has been limited to the destructive approaches of cryotherapy with liquid nitrogen and intralesional vinblastine. Although effective in the treatment of individual cutaneous lesions of Kaposi's sarcoma, these approaches are painful . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.